Trial search - ClinicalTrials.eu

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

ICP-332 for Adults with Prurigo Nodularis

Recruiting

2 1
Investigated drugs:
- 3-[(3AS,6AR)-5-{5-CHLORO-2-[(1-METHYL-1H-PYRAZOL-4-YL)AMINO]PYRIMIDIN-4-YL}-3A-METHYLHEXAHYDROPYRROLO[3,4-C]PYRROL-2(1H)-YL]-3-OXOPROPANENITRILE
Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

Recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Povorcitinib
+7
Study on the Effectiveness of Dupilumab Injections for Itch Relief in Adults with Lichen Simplex Chronicus

Not recruiting

3 1
Investigated drugs:
- Dupilumab
+1
Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

Not recruiting

3 1
Investigated diseases:
- Neurodermatitis
Investigated drugs:
- Rocatinlimab
+9
Study on the Effects of Povorcitinib for Patients with Prurigo Nodularis

Not recruiting

3 1
Study on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis

Not recruiting

3 1
Investigated drugs:
- Ruxolitinib
+1
Study on Dupilumab for Itch Relief in Adults with Lichen Simplex Chronicus (Neurodermatitis)

Not recruiting

3 1
Investigated drugs:
- Dupilumab
+2
Study on the Effects of Povorcitinib for Patients with Prurigo Nodularis

Not recruiting

3 1

+1
Study on the Effects of Barzolvolimab for Patients with Prurigo Nodularis

Not recruiting

2 1
Investigated drugs:
- Barzolvolimab
Study on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis

Not recruiting

3 1 1
Investigated drugs:
- Nemolizumab
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes